Becton Dickinson, a medical tech company, has singed a funding deal with Isla Care to further develop the company’s platform focused to support the assessment of post-surgery wounds.
The technology is used by patients and clinicians after surgery, to monitor wounds at home in the hope that it will encourage early detection and prevent infection.
By using it after surgery, patients can monitor and share updates on their wounds by presenting images from a smartphone, acting as a visual record.
The collaboration between Becton Dickinson and Isla Care aims to develop the existing Isla platform, with one area to create a tool that employs artificial intelligence to analyse the images submitted to detect early signs of wound infection.
Simon Noble-Clarke, UK Marketing Leader for Becton Dickinson, commented: “We are delighted to be collaborating with Isla Care and combining our expertise to create a ground-breaking tool that helps address a costly and time-consuming problem for the NHS and patients.
“Working with our collaborators to roll out these innovations underpins our commitment to tackling unmet needs, advancing the world of health and improving patient safety.”
Peter Hansell, Co-Founder of Isla Care, added: “We’re excited to be partnering with Becton Dickinson to take Isla to the next level, helping to increase staff capacity and patients to play a more active role in their wound care. ”
In October, HTN reported on news of Liverpool Heart and Chest Hospital introducing the technology.
